Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cardiac perfusion screening in patients to be treated with radiation therapy in the chest, is it a must?

× No keyword cloud information.

16 in total

1. Relation between clinical, angiographic and ischemic findings at baseline and ischemia-related adverse outcomes at 1 year in the Asymptomatic Cardiac Ischemia Pilot study. ACIP Study Group.

Authors: C J Pepine; B Sharaf; T C Andrews; S Forman; N Geller; G Knatterud; J Mahmarian; P Ouyang; W J Rogers; G Sopko; R Steingart; P H Stone; C R Conti
Journal: J Am Coll Cardiol Date: 1997-06 Impact factor: 24.094

2. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease.

Authors: Paul A Heidenreich; Ingela Schnittger; H William Strauss; Randall H Vagelos; Byron K Lee; Carol S Mariscal; David J Tate; Sandra J Horning; Richard T Hoppe; Steven L Hancock
Journal: J Clin Oncol Date: 2007-01-01 Impact factor: 44.544

3. Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults.

Authors: R L Larsen; R I Jakacki; V L Vetter; A T Meadows; J H Silber; G Barber
Journal: Am J Cardiol Date: 1992-07-01 Impact factor: 2.778

4. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study.

Authors: Maartje J Hooning; Berthe M P Aleman; Agnes J M van Rosmalen; Marianne A Kuenen; Jan G M Klijn; Flora E van Leeuwen
Journal: Int J Radiat Oncol Biol Phys Date: 2006-01-30 Impact factor: 7.038

5. The clinical implications of myocardial perfusion abnormalities in patients with esophageal or lung cancer after chemoradiation therapy.

Authors: Isis Gayed; Salman Gohar; Zhongxing Liao; Mary McAleer; Roland Bassett; Syed Wamique Yusuf
Journal: Int J Cardiovasc Imaging Date: 2009-02-22 Impact factor: 2.357

6. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy.

Authors: Matthew C Hull; Christopher G Morris; Carl J Pepine; Nancy Price Mendenhall
Journal: JAMA Date: 2003-12-03 Impact factor: 56.272

Cardiac perfusion screening in patients to be treated with radiation therapy in the chest, is it a must?

1. Relation between clinical, angiographic and ischemic findings at baseline and ischemia-related adverse outcomes at 1 year in the Asymptomatic Cardiac Ischemia Pilot study. ACIP Study Group.

2. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease.

3. Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults.

4. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study.

5. The clinical implications of myocardial perfusion abnormalities in patients with esophageal or lung cancer after chemoradiation therapy.

6. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy.

7. Asymptomatic cardiac disease following mediastinal irradiation.

8. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy.

9. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease.

10. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.